Okay. Great. Thank you, Stuart. I'm going to focus on our core operational performance upfront, where we did have terrific results, and then I'll address the legal charge and the technical accounting charge on the convertible notes and then finish up with guidance. So with that, I'll pick up on Slide 9. The core operational numbers really continued to trend well in Q2, as you heard from Stuart. Our agile, diversified, and global business model has consistently delivered growth as we are able to tap opportunities in the evolving markets we serve. Top line was up 8% and even a little more ex OEW with contribution from both segments. As Stuart mentioned earlier, EBITDA growth in Q2 was even more pronounced, registering at a strong 16% in the quarter, excluding the gains from disposal of nonstrategic assets we had in Q2 of last year. Both segments also contributed to the strong EBITDA growth, and it's also true margins at the consolidated level are continuing to improve as STS is covering a bigger portion of the mix. Adjusted EPS on the same basis was up double digits at 16% for all the same reasons, and actually a little ahead of our plan for the first half of the year. However, as you would expect, with higher interest rates, our election to accelerate paying off some of the convertible notes maturing later this year and with the legal settlement recently announced, interest expense will grow quite a bit in the second half. This increase will counterbalance the growth in EBITDA we are seeing from operations, which plays into holding our forward EPS guidance steady. We think all things considered, that's a good outcome given the risks we're retiring. More on this in a bit. Adjusted EBITDA and EPS excludes two significant nonrecurring charges worth discussing a little bit more here. The first is the $144 million pre-tax charge to settle the LOGCAP III QUI TAM case that we announced on July 3. This was excluded from adjusted EPS as it represents a legacy item from about a dozen years ago. The second is for the $314 million accounting charge, Stuart covered that earlier, related to actions we took to settle our convertible notes in cash and also the early retirement of $100 million in principle of such notes. I'll cover this in more detail shortly in terms of the accounting treatment, but it's important to note that due to the nature of these charges and as confirmed with our bank group, both of these will have no adverse impact on our EBITDA for credit borrowing base purposes and for covenant compliance purposes and thus, they will have no impact on liquidity. Big point. At the same time, both of these resolve or mitigate risk going forward, which is a positive. Over to cash. Cash flow from operations was really strong in Q2 over $250 million. with year-to-date cash conversion of almost 150% of adjusted net income. So hats off to the teams across both segments for strong performance, negotiating smarter commercial terms strong client collections and also other aspects of working capital management, which were spot on. Now I'll move on to Slide 10 with more details on the two segments. STS continues to have just a stellar year with revenues up 32% and EBITDA production up 45%, all organic. As Stuart covered earlier, strength in STS is well balanced across demand for energy transition and also energy security with clients increasingly trusting KBR to help drive decarbonization solutions all around the world. EBITDA margins were 20% for Q2, again, aided by strong licensing mix and also increased activity on our joint venture projects. For Government Solutions, revenues were up 6% on an ex OEW basis, good growth there. Our team continues to demonstrate ability to drive on-contract growth across its diverse book of business, which is a real vital important strength for KBR. International contribution and strong performance-based fees helped drive margins up to 11% in Q2, which obviously complemented the strong STS margins for an excellent quarter overall in terms of profitability. Now on to Slide 11 on capital and cash flow matters. With dividends being increased earlier this year and with buybacks, as Stuart said, $95 million was returned to shareholders in Q2, which together with Q1 amounts to over $170 million for the first half. In addition, as previously announced, we used about $200 million to accelerate the maturity of about 30% of our outstanding convertible notes and the associated note hedge and warrants. We did this to contain the overall cost of the maturity in the event we continue to see growth in our stock price as the year progresses. Having deployed this amount of capital, it is indeed notable, our leverage ratio just nudged up a notch from 1.9 last quarter to 2.0 this quarter. attributed to the strong growth we had in EBITDA and also the strong cash flow production in Q2. Now let me shed some light on how we see our capital position evolving in the next couple of quarters. While we took the P&L charge for the legacy legal settlement in Q2, the associated payment actually went out the door in Q3. So that will be reported in the third quarter. After that event, we have to deal with what remains of the convertible notes and the note hedge and those associated warrants. As reported and publicly filed transaction documents, the maturity of the notes and the note hedge is November one of this year, whereas the warrants mature between February and May of next year. At a $65 stock price assumption, the aggregate net value of the amount that remains outstanding across all three of these instruments as approximately $500 million. This, of course, will flow with any changes to our stock price. About half of that $500 million value is attributed to the convertible notes and the associated hedge again maturing November 1, which we've elected to settle in cash. The other half is attributable to the warrants, which may be settled in cash or shares, and we'll make the decision on those two methods later this year. We'll, of course, pursue maximizing free cash flow to fund these needs, but do expect borrowings to increase and thus have provided more interest expense in the outlook for the rest of this year. So I'll hit that in guidance here in a moment. Now let me touch on the accounting treatment for the convertible notes and note hedge. And indeed, the new rules on derivatives and hedge instruments do make this particularly complicated, so please bear with me. We said in prior calls, we intended to settle the convertible notes and note hedge in cash and in April, we made the required election to ensure that outcome. That election triggered different accounting treatment for the convertible notes and the note hedge. Previously, the notes and hedge qualify for equity exemption under accounting rule ASC 815 on derivatives and hedging because share settlement was an available option. However, once the cash settlement election was made, the convertible notes and note hedge no longer qualified for that exemption and consequently became subject to fair value measurement on the date we made that election. Oddly, the new rules apply this fair value treatment differently for the convertible notes on one hand and a corresponding hedge on the other. We are required to expense the fair value of the notes in the P&L and over quarters 2, 3 and 4 of this year until they mature. Whereas the economic benefit delivered by the hedge, is recorded to equity. That means the P&L does not reflect the economic benefit that the hedge truly delivers. That's the odd part. So as a result of all of that, we recorded a noncash charge in the P&L of $314 million related to the convertible notes and will also record an additional noncash charge of $152 million spread out over Q3 and Q4 of this year to reflect this accounting treatment I just summarized. So that sums it up. Let me just reemphasize the underlying economics to resolving all three of these elements of the convert are not different than what we have previously communicated. Our approach to resolve the whole matter remains as stated. And again, the accounting charges do not have any impact on our liquidity. So they do distort the P&L pretty significantly. But bear in mind, we're continuing to do, as we said we would do. get past this and maintain strong liquidity throughout and do so with minimal impact to KBR. So that's certainly our commitment. Now thanks for bearing all of that. I'm going to move on to our guidance on Slide 12. We Revenue guidance is unchanged at $6.9 billion to $7.1 billion for the year. However, with a strong operational performance in the first half, we are bumping up adjusted EBITDA to $730 million to $750 million. Our adjusted EPS guidance is unchanged at $2.76 per share to $2.96 per share. In short, the outflows for the convert and the legal settlement are considerably more than we anticipated at the start of this year and borrowings to cover those amounts are driving up interest expense that are offsetting the improved profit production we see from our operations. And finally, our adjusted operating cash flow guidance is unchanged at $425 million to $460 million, and that excludes the Ketan legal settlement as it would otherwise truly distort the cash flow performance that the business is producing. So summarizing this, the core business is performing really well, and we're increasing the outlook for production of operating profit from the business, a great testament to the performance of both STS and GS. This strong performance allows us to retain our adjusted EPS at the same level that we set out at the start of the year despite increased interest costs from higher rates, the interest associated with resolving the legacy matters and managing the convert as we've sat here and all doing so at a significantly higher stock price. So all things consider a remarkable story of positioning the business to tap attractive markets, generating strong cash flows and clearing the way with fewer constraints going forward. As we generate attractive levels of cash flow in future quarters, we expect to conduct a combination of buybacks, debt reduction and M&A to stay on course of our long-term targets, which we remain confident in achieving. With that, I'll turn it back to Stuart.